Benzinga | Aug 13, 2020 06:53AM EDT

HC Wainwright & Co. Maintains Neutral on Aerpio Pharmaceuticals, Raises Price Target to $2

HC Wainwright & Co. maintains Aerpio Pharmaceuticals (NASDAQ:ARPO) with a Neutral and raises the price target from $1.5 to $2.